August 2021
Volume 62, Issue 11
Open Access
ARVO Imaging in the Eye Conference Abstract  |   August 2021
Preferential Vulnerability of Capillary Occlusion in Sickle Cell Retinopathy
Author Affiliations & Notes
  • Oscar Otero-Marquez
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York City, New York, United States
  • Richard Rosen
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York City, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Maria Virginia Castanos Toral
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York City, New York, United States
  • Davis Zhou
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York City, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Justin Migacz
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York City, New York, United States
  • Alexander Pinhas
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York City, New York, United States
  • Peter Gillette
    Internal Medicine, SUNY Downstate Health Sciences University College of Medicine, New York, New York, United States
  • Jeffrey Glassberg
    Emergency Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Toco Chui
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York City, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Oscar Otero-Marquez, None; Richard Rosen, Astellas (C), Bayer (C), Boehringer-Ingelheim (C), CellView (C), Genentech-Roche (C), Guardion (I), OD-OS (C), Opticology (I), OptoVue (C), OptoVue (P), Regeneron (C), Teva (C); Maria Castanos Toral, None; Davis Zhou, None; Justin Migacz, None; Alexander Pinhas, None; Peter Gillette, None; Jeffrey Glassberg, None; Toco Chui, None
  • Footnotes
    Support  This study was supported by the National Eye Institute of the National Institutes of Health under award number R01EY027301. Additional funding for this research was provided by the Marrus Family Foundation, the New York Eye & Ear Foundation, the Challenge Grant award from Research to Prevent Blindness, and the Jorge N. Buxton Microsurgical Foundation.
Investigative Ophthalmology & Visual Science August 2021, Vol.62, 12. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Oscar Otero-Marquez, Richard Rosen, Maria Virginia Castanos Toral, Davis Zhou, Justin Migacz, Alexander Pinhas, Peter Gillette, Jeffrey Glassberg, Toco Chui; Preferential Vulnerability of Capillary Occlusion in Sickle Cell Retinopathy. Invest. Ophthalmol. Vis. Sci. 2021;62(11):12.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Capillary occlusion, leading to ischemic retinopathy, is a hallmark of sickle cell disease (SCD). However, the site of greatest vulnerability to capillary occlusion is controversial. In this study, we assessed the extent of peri-arteriolar and peri-venular non-perfusion in SCD patients with retinopathy using OCT-A as a clue to any preferential vulnerability.

Methods : Seventeen healthy controls (17 eyes) and 14 SCD patients (14 eyes) were imaged using a clinical SD-OCT system (Avanti RTVue-XR; Optovue). SCD patients were divided further into two subgroups according to their genotypes (5 HbSC and 9 HbSS). Ten 3x3mm OCT-A scans centered 9 degrees temporal to the fovea were acquired and averaged for each control and SCD patient (PMID: 28068370) (Fig. Top row). Peri-vascular capillary densities were measured using full vascular OCT-A slabs. First, arterioles and venules on the OCT-A were extracted using global thresholding (MATLAB, The MathWorks Inc., Natick, MA). Next, a 300 µm region of interest centered along the skeletonized arterioles and venules was generated. Peri-vascular capillary density measurements were performed on two pairs of adjacent arterioles and venules with similar caliber and length (Fig. Bottom row. Only one pair is shown). Arterioles and venules were pre-identified using the color fundus image. Axial length was obtained for ocular magnification correction of each measurement.

Results : Median ± interquartile range of peri-vascular capillary density (%) in controls, SCD HbSC, and SCD HbSS respectively, were 46.7±7.9, 41.8±15.3, and 40.6±15.7 for arterioles; and 51.5±5.2, 49.7±6.6, and 49.7±2.9 for venules. Peri-arteriolar capillary density was significantly different among groups (Kruskal-Wallis test, p = 0.003). Peri-arteriolar capillary density was significantly lower in the SCD HbSS group compared to the control group (pairwise comparison, p = 0.021). Peri-venular capillary density among groups showed no significant differences (Kruskal-Wallis test, p = 0.257).

Conclusions : Peri-vascular capillary density using OCT-A can be helpful for determining specific occlusive vulnerability. Our findings suggest that the most vulnerable site of vaso-occlusion is located adjacent to the arteriolar–capillary junctions. Further investigation into the regional variations of the vaso-occlusive events has the potential to enhance our understanding of the disease pathophysiology, severity, and treatment effect.

This is a 2021 Imaging in the Eye Conference abstract.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×